Emergencies preparedness, response

International Coordinating Group (ICG) on Vaccine Provision

WHO supports the immunization of 874 000 people against yellow fever in Nigeria


16 October 2017 - The Government of Nigeria has launched a campaign to immunize 873 837 people against yellow fever in the states of Kwara and Kogi. The ten-day campaign began on Friday, 13 October 2017, and mobilizes more than 200 health workers and volunteers.

The International Coordination Group (ICG) on Vaccine Provision for yellow fever is supporting the government of Nigeria with provision of much needed vaccines. A global stockpile of 6 million doses of the yellow fever vaccine is available for countries to access, with the support of Gavi, the Vaccine Alliance.

Large scale cholera vaccination campaign kicks off near Cox's Bazaar


10 October 2017 - The International Coordinating Group (ICG) on Vaccine Provision, with support from Gavi, the Vaccine Alliance, has released 900,000 doses of the Oral Cholera Vaccine (OCV) from the global stockpile to prevent the spread of cholera among recently arrived vulnerable populations and host communities in areas around Cox’s Bazar, Bangladesh. Large scale oral cholera immunization campaign started today.

Introductory-level online training module on accessing global vaccine stockpiles

WHO and partners – United Nations Children’s Fund (UNICEF), Médecins Sans Frontières (MSF) and International Federation of Red Cross and Red Crescent Societies (IFRC) – make emergency vaccine stockpiles available to countries to stop disease outbreaks.

Countries can now follow a simple online training module to help them quickly request the deployment of global vaccine stockpiles for managing cholera, meningitis and yellow fever outbreaks.

Evaluating two decades of ICG’s work into providing life-saving vaccines to contain disease outbreaks.

8 May 2017 - The Request for Proposals (RFP) for evaluation service providers has been launched on the UN Global Marketplace. The publication of the RFP marks the starting point of the External ICG mechanism evaluation. ICG member organizations (IFRC, MSF, Unicef, and WHO) and partners decided to conduct this evaluation in order to inform decisions aimed at improving ICG’s governance, its mechanism related to the management and accessibility of disease-specific, emergency stockpiles and their composition, the transparency of decision-making processes as well as ICG internal and external communication. The evaluation will also propose options for making the ICG mechanism fit-for-purpose for managing increasingly complex epidemics of the 21st century.

WHO and partners provide vaccines to control meningitis C in Nigeria

WHO/A. Clements-Hunt

13 April 2017 - A vaccination campaign is underway in Nigeria to contain an outbreak of meningitis C, a strain of meningitis which first emerged in the country in 2013. Since the beginning of this year, the country has reported 4637 suspected cases and 489 deaths across five states.

The International Coordinating Group (ICG) on Vaccine Provision, which coordinates the provision of emergency vaccine supplies during outbreak emergencies, has sent 500 000 doses of meningitis C-containing vaccine to Nigeria to combat the epidemic.

Review of the International Coordinating Group on Vaccine Provision (2006-2016)

Though outbreaks of meningitis, yellow fever and cholera are unpredictable events, they can each be controlled by the timely use of vaccine. Vaccine-preventable diseases typically affect people in vulnerable settings who have limited access to vaccines. But vaccines can take months to manufacture, and they are not always readily available in the amounts needed during emergencies. The resulting shortages have raised difficult issues about how limited supplies should be allocated during periods of high demand.

About the ICG on Vaccine Provision

The ICG is a mechanism to coordinate the provision of emergency vaccine supplies to countries during major outbreaks.

The ICG is composed of four member agencies: Médecins sans Frontières (MSF); International Federation of the Red Cross and Red Crescent Societies (IFRC), UNICEF and WHO. In addition to these members, additional expertise and technical advice is provided on a case-by-case basis from a range of partners.

The ICG was established in 1997, following major outbreaks of meningitis in Africa, as a mechanism to manage and coordinate the provision of emergency vaccine supplies and antibiotics to countries during major outbreaks. The ICG works to improve cooperation and coordination of epidemic preparedness and response. It also works on forecasting vaccine stocks, negotiating vaccine prices through its networks or partners, evaluating interventions and standard protocols for managing diseases.
Questions and answers about the ICG

The ICG aims to: rapidly deliver vaccines to respond to disease outbreaks; provide equitable vaccine allocation through careful risk assessment, based on epidemiological and operational criteria; coordinate the use of limited amounts of vaccines and essential medicines; reduce wastage of vaccines and supplies; advocate for readily available, low-cost vaccines and medicines; work with manufacturers through UNICEF and WHO to guarantee the availability of vaccine emergency stock supplies at the global levels; follow standard operating procedures and establish financial mechanisms to purchase emergency vaccine supplies and ensure their sustainability.

The ICG is made up of four member agencies: IFRC, MSF, UNICEF and WHO. Additional expertise and technical advice is provided on a case-by-case basis from partners including: Agence de Médecine Preventive in Paris, Epicentre in Paris, GAVI the Vaccine Alliance, WHO Collaborating Centres, the US Centers for Disease Control and the European Community Humanitarian Office (ECHO). Vaccine manufacturers, vaccine equipment providers and financial donor institutions are also engaged in the ICG operations.

ICGs have been established to provide access to vaccines for the following diseases: cholera, meningitis and yellow fever.

About the meningitis stockpile
About the yellow fever stockpile
About the cholera stockpile

For information regarding the current availability of vaccine stockpiles for meningitis, yellow fever and cholera, please visit the link below.

Current availability of emergency vaccine stockpiles

These dashboards are designed to record essential information on vaccines requested and doses delivered through the International Coordinating Group on Vaccine Provision.

Dashboard on meningitis
Dashboard on yellow fever
Dashboard on cholera

These interactive maps of International Coordinating Group for Vaccine Provision show where and when the vaccines for cholera, meningitis and yellow fever have been requested and delivered globally.

See the map for meningitis
See the map for yellow fever
See the map for cholera

ICG for meningitis


The ICG on Vaccine Provision for Epidemic Meningitis Control was established in January 1997, following major outbreaks of meningitis in Africa. From 2009 to 2016, 20 million doses of vaccines were shipped for emergency response in 13 countries.

ICG for yellow fever

WHO/E. Soteras Jalil

In 2000 a global shortage of yellow fever vaccine occurred, mainly due to a combination of the relatively long time needed to produce the vaccine, and poor epidemiological surveillance and reporting in at-risk countries which made forecasting vaccine needs difficult.

Technical and general information on the ICG

ICG for cholera


The ICG manages the global stockpile of oral cholera vaccine which was created as an additional tool to help control cholera epidemics. Since July 2013, the ICG has released more than 5 million doses of oral cholera vaccines to affected countries.

Contact information

Department of Pandemic and Epidemic Diseases
World Health Organization
Avenue Appia 20
1211 Geneva 27